John Ruckdeschel
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer survivorship and care
- Peptidase Inhibition and Analysis
-
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 3
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Giuseppe Giaccone (1 shared paper)Paul S. Thomas (1 shared paper)Thomas E. Lad (1 shared paper)David Payne (1 shared paper)Steven Piantadosi (1 shared paper)Mark M. Zalupski (1 shared paper)Darlene Mood (1 shared paper)Trace Kershaw (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)CHEST Journal (1 paper)Medicine (1 paper)Transplantation (1 paper)Psycho-Oncology (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
John Ruckdeschel
7 papers receiving 568 citations
Peers
Comparison fields: 5 of 67
- Oncology 366
- Epidemiology 207
- Pulmonary and Respiratory Medicine 158
- Public Health, Environmental and Occupational Health 140
- Pediatrics, Perinatology and Child Health 72
Countries citing papers authored by John Ruckdeschel
This map shows the geographic impact of John Ruckdeschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ruckdeschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ruckdeschel more than expected).
Fields of papers citing papers by John Ruckdeschel
This network shows the impact of papers produced by John Ruckdeschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ruckdeschel. The network helps show where John Ruckdeschel may publish in the future.
Co-authors
The 25 scholars most cited alongside John Ruckdeschel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 225 | |
| 2 | 2012 | 191 | |
| 3 | 2013 | 82 | |
| 4 | 1975 | 55 | |
| 5 | 2009 | 28 | |
| 6 | Chemotherapy for esophageal cancer with mitoguazone, methotrexate, bleomycin, and cisplatin. | 1985 | 7 |
| 7 | 1977 | 4 |
About John Ruckdeschel
John Ruckdeschel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Cancer Research and Surgery, having authored 7 papers that have together received 592 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Treatment and Pharmacology (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Selenium in Biological Systems (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Oncology (366 citations), Epidemiology (207 citations), Pulmonary and Respiratory Medicine (158 citations), Public Health, Environmental and Occupational Health (140 citations) and Pediatrics, Perinatology and Child Health (72 citations). John Ruckdeschel has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Giuseppe Giaccone, Paul S. Thomas, Thomas E. Lad, David Payne, Steven Piantadosi, Mark M. Zalupski, Darlene Mood, Trace Kershaw, Daniel F. Hayes and Ann Schafenacker. Their work appears in journals such as Journal of Clinical Oncology, CHEST Journal, Medicine, Transplantation and Psycho-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.